IBC s 5th
5th Annual Generics Asia Summit 2010 is THE meeting place for C-level decision makers from generics companies, pharmas, payers, investors, regulators and health authorities to discuss business strategy and to form partnerships in an evolving and ultra-competitive industry.
Be part of the only conference in Asia focused on generics strategies. Join thoughtleaders, health authorities, decision makers from major generics companies and innovators from Indonesia, China, Philippines, Japan, Malaysia, India, Australia, Singapore, Israel, USA and Europe as they gather to map the industry s rise and future:
- Assess the impact of game changing moves on your business
- Meet with and gather rare insights from global and regional generics industry and pharma executives
- Equip your business with the information necessary to re-align your strategy
- Take full advantage of incisive, up-todate, in-depth workshops addressing generics and biosimilars strategy, bioequivalence, regulatory and legal challenges
The conference programme is currently being researched; preliminary sessions and discussions will include:
- Game changing developments in the generics industry and impetus from major pharma
- Funding/investment sources
- Branding, sales and market entry strategies
- Funding/investment sources Reimbursement and future role of retailers, online and alternative channels for generics companies
- Evolving & Regulatory updates , compliance and approvals in developed and emerging markets
- Biosimilars / Biobetters and emerging opportunities for Branded / Supergenerics
